Wall Street Hedge

Thursday, January 21, 2021
Log in
  • Home
  • Nation & Politics
  • Financial News
  • Technology & Research
  • Lifestyle & Health
    • Latest News
      • Business
      • Nature
      • Science
      • World
      • VA Hospitals Are Still Under Investigation for Suspected Drug Thefts

Pfizer Drops Research for Alzheimer’s and Parkinson’s Treatments

By Leave a Comment

 

Pfizer Inc said it will shut down its neurosciences research branch.

Pfizer Inc announced it will discontinue its research into Alzheimer’s and Parkinson’s treatments.

Biopharmaceutical company, Pfizer Inc, announced it will shut down its neuroscience research branch, leaving 300 people without a job in the process. The exit will also see Pfizer drop all research into potential treatments for Parkinson’s and Alzheimer’s disease.

Pfizer’s decision to steer away from the neuroscience business was due to the company’s wish to redeploy resources. As a result, employees working in Pfizer’s Massachusetts and Connecticut offices will be affected by the restructuring.

While the company will no longer invest in Alzheimer’s and Parkinson’s treatment, they will continue their joint partnership with Eli Lilly and Co., another global pharmaceutical company. The two companies developed a drug called tanezumab which prevents nerve growth and is used to alleviate pain caused by osteoporosis. Pfizer also announced it will still continue its Research and Development programs for the drug Lyrica, another drug used for pain treatment this time caused by diabetes, shingles and spinal cord injuries.

The company’s announcement was not received with much fanfare.

“It’s really alarming to see such a large pharmaceutical company deciding to abandon research into brain and central nervous system,” said James Beck, chief scientific officer at the Parkinson’s Foundation on Monday.

According to Beck, Pfizer’s move can stir similar sentiments in other biopharmaceutical companies who dabble in the neuroscience research sector.

Research into Parkinson’s has been a difficult endeavor in the past decade, let alone for Alzheimer’s. According to the Parkinson’s Foundation, over 1 million Americans have Parkinson’s disease.

Pfizer is also said to be considering the creation of a finance arm that could have a structure similar to that of a venture, however, details on this are scarce. Sources claim that the company was considering the idea at the JPMorgan Healthcare Conference in San Francisco on Monday.

Pfizer shares were down 1.1 percent to $36.47 on Monday.

Image Source: WikipediaCommons

Share this:

  • Tweet
  • Share on Tumblr

Filed Under: Business

Leave a Reply Cancel reply

You must be logged in to post a comment.

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 15 other subscribers

Recent Articles

AXA building in Wiesbaden, Germany.

Insurer AXA To Buy XL Group For $15 Billion

By Leave a Comment

New York Stock Exchange on Wall Street.

Wall Street Comes Out Intact As Global Stock Rise

By Leave a Comment

Ryanair profits are up despite threats of pilot strike.

Ryanair Profits Are Up But A New Pilot Strike May Be Around The Corner

By Leave a Comment

Bitcoin bubble may burst, analysts speculate.

Bitcoin Bubble Shows Signs Of Bursting

By Leave a Comment

One percent amassed 82 percent of the world's fortune last year.

82 Percent Of The World’s Wealth Went To The One Percent In 2017, According To Oxfam Report (Report)

By Leave a Comment

Morgan Stanley will be hit with a $1.25 billion charge as part of the new Republican tax cut.

Morgan Stanley To Be Hit With $1.25 Billion Charge From Republican Tax Reform

By Leave a Comment

General Electric Laboratory

High Demand For Renewable Forces General Electric To Slash 12 Thousand Jobs Worldwide

By Leave a Comment

Cryptocurrency bitcoin coins

Cryptocurrency Is Worth More Than JPMorgan, Bitcoin Raises Concerns

By Leave a Comment

Computer circuit board

Chipmaker Company, Marvell Technology, to Buy its Rival Cavium in $6 billion Deal

By Leave a Comment

Thanksgiving dinner

Thanksgiving Dinner Will Cost Less This Year as Food Gets Cheaper

By Leave a Comment

Doctors in surgery

Vermont Is Preparing New Health Care System

By Leave a Comment

Saudi Arabia’s capital city Riyadh

Saudi Arabia Has Just Bought Huge Stake in Uber

By Leave a Comment

No Agreement Yet on the Trans-Pacific Partnership

By Leave a Comment

Samsung Shareholders Approve Deal Which Sees Lee Family Gain More Control

By Leave a Comment

Related Articles

  • Toys R Us In Clay, New York.

    Toys R Us Is Not Showing Signs Of Improvement, May Close Additional 200 Stores

  • Remington R4 Rifle markings

    US Gunmaker, Remington, Will File For Bankruptcy

  • Snapchat reassures investors it remains a profitable app.

    Snapchat Reassures Investors It Is Still A Relevant App

  • WhatsApp Business app released to select market.

    The WhatsApp Business App Is Now Available In Select Markets

  • Boeing cofirms takeover talks with Embraer.

    Boeing In Talks To Acquire Brazilian Aerospace Conglomerate, Embraer

  • Penske Media buys majority stake in Rolling Stone magazine.

    Penske Media Buys Majority Stake In Rolling Stone Magazine

  • European Union imposes vehicle transportation system regulation on Uber.

    The European Union Considers Uber To Be Nothing More Than A Taxi Company

  • Ryanair wants to prevent a pilot strike during the holidays.

    Ryanair Recognizes Pilot Unions In An Attempt To Avoid A Holiday Strike

  • Airbus A320 and Boeing 737 in flight.

    Delta May Give 13 Billion Jet Order To Airbus Instead Of Boeing

  • Providence St. Joseph medical center in Burbank, Califfornia.

    Providence St. Joseph and Ascension Merger To Become Largest Hospital Operator in the US

Categories

  • Business
  • Entertainment
  • Financial News
  • Lifestyle & Health
  • Nation & Politics
  • National News
  • Nature
  • Science
  • Technology & Research
  • World

Copyright © 2021 WallStreetHedge.com

About · Privacy Policy · Terms of Use · Contact

This website uses cookies to ensure you get the best experience on our website. Learn more.